Mark S. Levine serves as Chief Legal and Administrative Officer and Secretary at 908 Devices Inc., a pioneering company in handheld chemical analysis and diagnostics. In this multifaceted role, he leads the company's legal strategy, including intellectual property protection, regulatory compliance, corporate governance, and risk management. Levine also oversees administrative operations, ensuring seamless support for the organization's innovation in portable mass spectrometry devices used by first responders, researchers, and industrial professionals. His strategic oversight has been instrumental in navigating complex FDA regulations and supporting the company's growth through successful financings and partnerships. With over 25 years of experience in the life sciences and technology sectors, Levine brings a proven track record of guiding high-growth companies through pivotal milestones. Prior to joining 908 Devices in 2020, he served as General Counsel at Bluebird bio, where he managed global legal operations during a period of rapid expansion, including multiple public offerings and international collaborations. Earlier in his career, he held senior legal roles at PerkinElmer and Genzyme Corporation, specializing in mergers and acquisitions, licensing agreements, and litigation that protected critical IP portfolios and drove multimillion-dollar deals. Levine's achievements include spearheading compliance programs that mitigated regulatory risks and facilitating strategic alliances that accelerated product commercialization. A graduate of Harvard Law School and a former partner at a leading Boston law firm, he is recognized for his pragmatic approach to legal challenges in emerging technologies, earning accolades from industry peers for fostering innovation while upholding the highest ethical standards.